Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CDA”

188 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 188 results

Testing effectiveness (Phase 2)Study completedNCT02044796
What this trial is testing

Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Who this might be right for
Acute Biphenotypic Leukemiade Novo Myelodysplastic SyndromePreviously Treated Myelodysplastic Syndrome+3 more
Fred Hutchinson Cancer Center 199
Not applicableActive Not RecruitingNCT05797740
What this trial is testing

Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)

Who this might be right for
Multiple Sclerosis
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 367
Not applicableStudy completedNCT06415864
What this trial is testing

Oral Cladribine B-cell Study

Who this might be right for
Multiple Sclerosis
Queen Mary University of London 10
Testing effectiveness (Phase 2)UnknownNCT04254640
What this trial is testing

Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML

Who this might be right for
Acute Myeloid LeukemiaElderly PatientsNewly Diagnosed
Sun Yat-sen University 34
Large-scale testing (Phase 3)Looking for participantsNCT02131753
What this trial is testing

Therapy Optimisation for the Treatment of Hairy Cell Leukemia

Who this might be right for
Hairy Cell Leukemia
University of Giessen 210
Not applicableStudy completedNCT03403231
What this trial is testing

INcreasing Veteran EngagemeNT to Prevent Diabetes (INVENT)

Who this might be right for
Prediabetes
VA Office of Research and Development 144
Post-approval studies (Phase 4)UnknownNCT05902429
What this trial is testing

Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Pontificia Universidade Católica do Rio Grande do Sul 10
Large-scale testing (Phase 3)UnknownNCT01602939
What this trial is testing

Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis

Who this might be right for
Systemic Mastocytosis
Hospital Virgen de la Salud 10
Not applicableActive Not RecruitingNCT05990075
What this trial is testing

An eHealth Intervention to Increase Depression Treatment Initiation and Adherence Among Veterans Referred for Mental Health Services

Who this might be right for
Depression
VA Office of Research and Development 47
Early research (Phase 1)Active Not RecruitingNCT06021600
What this trial is testing

A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine

Who this might be right for
LeukemiaMyelodysplastic SyndromesAcute Myeloid Leukemia
M.D. Anderson Cancer Center 40
Early research (Phase 1)Study completedNCT00003174
What this trial is testing

Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Barbara Ann Karmanos Cancer Institute 80
Testing effectiveness (Phase 2)Study completedNCT00980395
What this trial is testing

Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma

Who this might be right for
LymphomaMantle Cell LymphomaIndolent Lymphoma+1 more
University of Arizona 24
Testing effectiveness (Phase 2)Study completedNCT05906914
What this trial is testing

Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, Adult
First Affiliated Hospital of Zhejiang University 65
Testing effectiveness (Phase 2)Study completedNCT03882203
What this trial is testing

CLAGE Sequential With Flu-Bu Conditioning for Refractory Acute Leukemia

Who this might be right for
Refractory Hematologic CancerAllogeneic Stem Cell Transplantation
Shanghai Jiao Tong University School of Medicine 18
Early research (Phase 1)WithdrawnNCT06007911
What this trial is testing

Venetoclax-Navitoclax With Cladribine-based Salvage Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed Adult AMLRefractory AML
Medical College of Wisconsin
Not applicableStudy completedNCT04934800
What this trial is testing

Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)

Who this might be right for
Multiple Sclerosis
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 256
Not applicableLooking for participantsNCT06854094
What this trial is testing

Consolidation Therapy with Cladribine in Relapsing Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Ente Ospedaliero Cantonale, Bellinzona 70
Large-scale testing (Phase 3)Temporarily pausedNCT03610100
What this trial is testing

Acelarin First Line Randomised Pancreatic Study

Who this might be right for
Pancreatic Acinar CarcinomaPancreatic Neoplasms
The Clatterbridge Cancer Centre NHS Foundation Trust 328
Early research (Phase 1)UnknownNCT03235973
What this trial is testing

Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute
Institut Paoli-Calmettes 29
Post-approval studies (Phase 4)Study completedNCT04135937
What this trial is testing

Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)

Who this might be right for
Human Immunodeficiency VirusSmoking
VA Office of Research and Development 12
Load More Results